MKI67 and breast cancer: In addition, the downregulation of proliferation markers such as Ki67 and cyclin-dependent kinases (CDKs) [57], and upregulation of the CDK inhibitors p16 and p27 in hypoxic BC cells [58, 59], confirms a key role of hypoxia on dormancy.